பால பேட்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பால பேட்ஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பால பேட்ஸ் Today - Breaking & Trending Today

Grant launched to look at solving problems from pandemic


By TOM LATEK
Kentucky Today
Apr 23, 2021
3 hrs ago
LOUISVILLE, Ky. (KT) – The University of Louisville has received $750,000 from the U.S. Economic Development Administration to launch a new program aimed at solving long-term health, economic and societal problems resulting from the COVID-19 pandemic. 
The Pandemic-Related Product Acceleration & Responsive Entrepreneurship Program, or PRePARE, UofL researchers will join with members of the community, on innovative ideas that can expand existing companies or start new ones to bring those ideas to market.
Potential ideas include ways to track viral spread more efficiently, expand access to virtual services, or bring employees back to work safely. ....

Kevin Gardner , Paula Bates , Us Economic Development Administration , Product Acceleration Responsive Entrepreneurship Program , Kentuckiana Regional Planning Development Agency , University Of Louisville , Development Administration , Pandemic Related Product Acceleration , Responsive Entrepreneurship Program , Kentuckiana Regional Planning , Development Agency , கெவின் கார்ட்னர் , பால பேட்ஸ் , பல்கலைக்கழகம் ஆஃப் லூயிஸ்வில்லி , கெண்டுக்கியன பிராந்திய திட்டமிடல் ,

UofL cancer researcher Paula Bates named EPIC Innovator of the Year


2020 UofL EPIC Innovation Awards winners (from left) Paula Bates, Brad Shuck, Theo Edmonds and Laura Weingartner.
University of Louisville researchers and innovators love a good challenge. And in 2020 a year of challenges they continued pushing forward, creating and commercializing groundbreaking technologies that can improve the way we work and live. They were recognized for those contributions at the presentation of the second annual EPIC Innovation Awards, held January 28. 
“Innovation is absolutely critical to UofL’s mission,” said UofL President Neeli Bendapudi. “It’s what drives us and inspires us. Our three most important goals as a university are to be a great place to learn, to work and to invest, and the work of these innovators contributes to all three.”  ....

Kevin Gardner , Paula Bates , Theo Edmonds , Laura Weingartner , Neeli Bendapudi , Allen Morris , Human Development , Office Of The Executive Vice , Uofl College Of Education , University Of Louisville , Brad Shuck , Uofl President Neeli , Executive Vice President , Year Award , Cultural Wellbeing Index , Employee Engagement Scale , Uofl College , Equality Toolkit , Practical Skills , Affected Patient Care , கெவின் கார்ட்னர் , பால பேட்ஸ் , தியோ எட்மண்ட்ஸ் , லாரா வேங்கர்த்தினேற் , நீலி பெண்டபுடி , ஆலன் மோரிஸ் ,

Scarborough hotel couple are eager to welcome their first guests


Tony and Paula Bates outside Hotel Ellenby
The pandemic has seen impacted businesses in a number of ways, but what happens when your business hasn’t even begun to trade?
This was the scenario facing Tony and Paula Bates who bought the Hotel Ellenby in Queens Parade, Scarborough, earlier this year.
“We started planning a year ago. We had a sign and graphics business in Nottinghamshire and we decided to put it up for sale,” said Tony.
Tony and Paula look forward to welcoming their first guests
“Much to our surprise, the business sold during lockdown, which we didn’t expect, because running any business during lockdown is not much fun. ....

United Kingdom , Paula Bates , Hotel Ellenby , Queens Parade , Tier Three , ஒன்றுபட்டது கிஂக்டம் , பால பேட்ஸ் , ராணிகள் அணிவகுப்பு , அடுக்கு மூன்று ,

Qualigen Therapeutics Announces Issuance of U.S. Patent for Expanded Applications of ALAN Anticancer Platform Technology


Press release content from PR Newswire. The AP news staff was not involved in its creation.
Qualigen Therapeutics Announces Issuance of U.S. Patent for Expanded Applications of ALAN Anticancer Platform Technology
December 15, 2020 GMT
CARLSBAD, Calif., Dec. 15, 2020 /PRNewswire/ Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a biotechnology company focused on developing novel therapeutics for the treatment of cancer and infectious diseases, today announced that the United States Patent and Trademark Office has issued a patent entitled “Anti-Nucleolin Agent-Conjugated Nanoparticles as Radio-Sensitizers and/or MRI Contrast Agents” regarding the Company’s ALAN (Aptamer-Linked Anti-Nucleolin) technology. This patent issued to the University of Louisville (UofL) protects the ALAN technology for use with cancer radiation therapy and for imaging tumors utilizing magnetic resonance imaging (MRI). The novel ALAN technology has several other potential applications, includin ....

United States , Paula Bates , Michael Poirier , University Of Louisville Uof , Sekisui Diagnostics , Qualigen Therapeutics Inc , Trademark Office , Exchange Commission , Prnewswire Qualigen Therapeutics Inc , Qualigen Inc , Company Fastpack , Emergency Use Authorization For The Company , United States Patent , Nucleolin Agent Conjugated Nanoparticles , Aptamer Linked Anti Nucleolin , Chief Executive Officer , Qualigen Therapeutics , Fastpack System , Emergency Use Authorization , Private Securities Litigation Reform Act , ஒன்றுபட்டது மாநிலங்களில் , பால பேட்ஸ் , மைக்கேல் போய்ரிிஎற் , செக்கிசுய் பரிசோதனை , முத்திரை அலுவலகம் , பரிமாற்றம் தரகு ,